|
業務類別
|
-- |
|
業務概覽
|
WuXi Biologics is one of the largest biologics contract development and manufacturing organizations in the world. Incorporated in 2014 following the reorganization of WuXi PharmaTech, WuXi engages in full-lifecycle services beginning from drug discovery, clinical trials, and commercial manufacturing. It focuses on developing refining and manufacturing processes to increase scalability and efficiency for pharmaceutical companies looking to outsource and access specialized knowledge. As of 2024, WuXi derives more than 60% of its revenue from US companies and focuses its operations on high-growth, late-stage, and commercial projects in the biologics sector. WuXi competes with Samsung Biologics, Lonza, and Fujifilm for contracts. |
| 公司地址
| No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092 |
| 電話號碼
| +86 51085353482 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.wuxibiologics.com |
| 員工數量
| 13252 |
| Dr. Zhisheng Chen, PhD |
Chief Executive Officer and Director |
-- |
29/04/2026 |
| Dr. Sherry Xuejun Gu, PhD |
Director and Chief Technology Officer |
-- |
29/04/2026 |
|
|
| Mr. Jackson Peter Tai |
Independent Director |
29/04/2026 |
| Mr. William Robert Keller |
Independent Director |
29/04/2026 |
| Mr. Yanling Cao |
Director |
29/04/2026 |
| Mr. Kenneth Walton Hitchner, III |
Independent Director |
29/04/2026 |
| Dr. Zhisheng Chen, PhD |
Chief Executive Officer and Director |
29/04/2026 |
| Dr. Ge Li, PhD |
Chairman of the Board |
29/04/2026 |
| Professor Dr. Jue Chen, PhD |
Independent Director |
29/04/2026 |
| Ms. Jingwen Miao |
Director |
29/04/2026 |
| Dr. Sherry Xuejun Gu, PhD |
Director and Chief Technology Officer |
29/04/2026 |
|
|
|
|
